Related Experiment Video

Updated: Aug 15, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

The Edinburgh City Hospital cohort: analysis of enrollment, progression and mortality by baseline covariates

R P Brettle1, A J McNeil, S M Gore

  • 1Regional Infectious Disease Unit, City Hospital, Edinburgh.

QJM : Monthly Journal of the Association of Physicians
|July 1, 1995
PubMed

Insights

HIV progression varies by risk group and age. Homosexual men and older patients experienced faster CD4 cell loss and poorer survival, while younger patients progressed slower. Zidovudine improved survival post-AIDS diagnosis.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Epidemiology

Background:

  • The Edinburgh City Hospital HIV cohort provides valuable data on human immunodeficiency virus (HIV) progression.
  • Understanding demographic and behavioral factors influencing HIV disease progression is crucial for patient management and public health strategies.

Purpose of the Study:

  • To characterize the baseline features, enrollment patterns, disease progression, and mortality within the Edinburgh City Hospital HIV cohort.
  • To identify factors associated with the rate of CD4 cell loss, progression to Acquired Immunodeficiency Syndrome (AIDS), and survival post-diagnosis.

Main Methods:

  • Retrospective analysis of 622 patients (431 men, 191 women) in the Edinburgh City Hospital HIV cohort.
  • Assessment of baseline characteristics, routes of HIV infection (injection drug use, homosexual/heterosexual intercourse, blood products), and CD4 cell counts.
  • Multifactorial analysis to evaluate the impact of gender, age, and transmission route on disease progression (CDC stage IV, AIDS, death) and survival.

Main Results:

  • Injection drug use (IDU) was the predominant transmission route (71%).
  • Homosexual men and patients over 40 lost CD4 cells faster. Young patients (<25) showed slower progression to AIDS.
  • Homosexual men had a significantly higher risk of progressing to CDC stage IV, AIDS, and death compared to IDUs. Survival post-AIDS was 25% at three years, with poorer outcomes for those diagnosed in their 40s or later. Zidovudine treatment showed a trend towards improved post-AIDS survival.

Conclusions:

  • HIV disease progression and survival are influenced by transmission route and age at diagnosis.
  • Specific risk groups, such as homosexual men, face accelerated disease progression.
  • Age is a significant factor in survival post-AIDS diagnosis, and early treatment interventions like Zidovudine may offer survival benefits.

Related Concept Videos

Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...